Literature DB >> 23041118

Experimentally induced blood stage malaria infection as a tool for clinical research.

Christian R Engwerda1, Gabriela Minigo, Fiona H Amante, James S McCarthy.   

Abstract

A system for experimentally induced blood stage malaria infection (IBSM) with Plasmodium falciparum by direct intravenous inoculation of infected erythrocytes was developed at the Queensland Institute of Medical Research (QIMR) more than 15 years ago. Since that time, this system has been used in several studies to investigate the protective effect of vaccines, the clearance kinetics of parasites following drug treatment, and to improve understanding of the early events in blood stage infection. In this article, we will review the development of IBSM and the applications for which it is being employed. We will discuss the advantages and disadvantages of IBSM, and finish by describing some exciting new areas of research that have been made possible by this system.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23041118     DOI: 10.1016/j.pt.2012.09.001

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  35 in total

Review 1.  Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease.

Authors:  Peter D Crompton; Jacqueline Moebius; Silvia Portugal; Michael Waisberg; Geoffrey Hart; Lindsey S Garver; Louis H Miller; Carolina Barillas-Mury; Susan K Pierce
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

2.  Profoundly Reduced CD1c+ Myeloid Dendritic Cell HLA-DR and CD86 Expression and Increased Tumor Necrosis Factor Production in Experimental Human Blood-Stage Malaria Infection.

Authors:  Jessica R Loughland; Gabriela Minigo; Julie Burel; Peta E Tipping; Kim A Piera; Fiona H Amante; Christian R Engwerda; Michael F Good; Denise L Doolan; Nicholas M Anstey; James S McCarthy; Tonia Woodberry
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

Review 3.  Malaria medicines: a glass half full?

Authors:  Timothy N C Wells; Rob Hooft van Huijsduijnen; Wesley C Van Voorhis
Journal:  Nat Rev Drug Discov       Date:  2015-05-22       Impact factor: 84.694

4.  Preserved dendritic cell HLA-DR expression and reduced regulatory T cell activation in asymptomatic Plasmodium falciparum and P. vivax infection.

Authors:  Steven Kho; Jutta Marfurt; Rintis Noviyanti; Andreas Kusuma; Kim A Piera; Faustina H Burdam; Enny Kenangalem; Daniel A Lampah; Christian R Engwerda; Jeanne R Poespoprodjo; Ric N Price; Nicholas M Anstey; Gabriela Minigo; Tonia Woodberry
Journal:  Infect Immun       Date:  2015-06-01       Impact factor: 3.441

5.  What goes around comes around: modeling malaria transmission from humans back to mosquitos.

Authors:  Kazutoyo Miura; Peter D Crompton
Journal:  J Clin Invest       Date:  2018-03-12       Impact factor: 14.808

6.  Evaluating the pharmacodynamic effect of antimalarial drugs in clinical trials by quantitative PCR.

Authors:  Louise Marquart; Mark Baker; Peter O'Rourke; James S McCarthy
Journal:  Antimicrob Agents Chemother       Date:  2015-05-11       Impact factor: 5.191

7.  Experimentally induced blood-stage Plasmodium vivax infection in healthy volunteers.

Authors:  James S McCarthy; Paul M Griffin; Silvana Sekuloski; A Taylor Bright; Rebecca Rockett; David Looke; Suzanne Elliott; David Whiley; Theo Sloots; Elizabeth A Winzeler; Katharine R Trenholme
Journal:  J Infect Dis       Date:  2013-08-01       Impact factor: 5.226

8.  Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection.

Authors:  Joshua M Obiero; Seif Shekalaghe; Cornelus C Hermsen; Maxmillian Mpina; Else M Bijker; Meta Roestenberg; Karina Teelen; Peter F Billingsley; B Kim Lee Sim; Eric R James; Claudia A Daubenberger; Stephen L Hoffman; Salim Abdulla; Robert W Sauerwein; Anja Scholzen
Journal:  Infect Immun       Date:  2015-03-16       Impact factor: 3.441

9.  Dichotomous miR expression and immune responses following primary blood-stage malaria.

Authors:  Julie G Burel; Simon H Apte; Penny L Groves; Michelle J Boyle; Christine Langer; James G Beeson; James S McCarthy; Denise L Doolan
Journal:  JCI Insight       Date:  2017-08-03

10.  Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01.

Authors:  Ruth O Payne; Kathryn H Milne; Sean C Elias; Nick J Edwards; Alexander D Douglas; Rebecca E Brown; Sarah E Silk; Sumi Biswas; Kazutoyo Miura; Rachel Roberts; Thomas W Rampling; Navin Venkatraman; Susanne H Hodgson; Geneviève M Labbé; Fenella D Halstead; Ian D Poulton; Fay L Nugent; Hans de Graaf; Priya Sukhtankar; Nicola C Williams; Christian F Ockenhouse; April K Kathcart; Aziz N Qabar; Norman C Waters; Lorraine A Soisson; Ashley J Birkett; Graham S Cooke; Saul N Faust; Colleen Woods; Karen Ivinson; James S McCarthy; Carter L Diggs; Johan Vekemans; Carole A Long; Adrian V S Hill; Alison M Lawrie; Sheetij Dutta; Simon J Draper
Journal:  J Infect Dis       Date:  2016-02-04       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.